Storia della carriera di Paul F. Howley
Precedenti posizioni note di Paul F. Howley
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PRESCIENT THERAPEUTICS LIMITED | Direttore Tecnico/Scientifico/R&S | 01/01/2008 | 01/01/2008 |
| BAVARIAN NORDIC A/S | Direttore Tecnico/Scientifico/R&S | 01/01/2002 | 01/01/2002 |
Sentinext Therapeutics Sdn. Bhd.
 Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Corporate Officer/Principal | 05/04/2010 | - |
Formazione di Paul F. Howley
| The University of Reading | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Malesia | 2 |
| Regno Unito | 2 |
| Danimarca | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BAVARIAN NORDIC A/S | Health Technology |
| PRESCIENT THERAPEUTICS LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Health Technology |
- Borsa valori
- Insiders
- Paul F. Howley
- Esperienza
